Exploring Clinical Class 1 Integrons as Valuable Targets for the Re-sensitization of Multidrug Resistant Pathogenic Bacteria Using CRISPR-Cas
Anna Berggreen Skovmand, Nicolai Juel Paaske, Arancha Peñil-Celis, Amalie Elisabeth Schønemann, Lærke Lund Hansen, Witold Kot, Maria Pilar Garcillán-Barcia, Tue Kjærgaard Nielsen
This study explores using CRISPR-Cas to target class 1 integrons in multidrug-resistant bacteria to re-sensitize them to antibiotics by removing resistance genes.
bioRxiv · Mar 28, 2025 · PreprintMicrobiology